Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving viable micro-organism
Reexamination Certificate
2007-09-18
2007-09-18
Graser, Jennifer E. (Department: 1645)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving viable micro-organism
C435S004000, C435S007310, C435S007800, C435S026000, C435S029000
Reexamination Certificate
active
10313371
ABSTRACT:
The invention relates to polypeptides from phytopathogenic fungi with the biological activity of an inosine monophosphate dehydrogenase, to nucleic acids encoding them, to the use of the polypeptides and nucleic acids for identifying modulators of the polypeptides, to methods for identifying such modulators, and to the use of these modulators as fungicides.
REFERENCES:
patent: 5976848 (1999-11-01), Davis et al.
patent: 6376216 (2002-04-01), Doval et al.
patent: 6391603 (2002-05-01), Pompejus et al.
patent: 95/11969 (1995-05-01), None
patent: 97/44484 (1997-11-01), None
patent: 98/32847 (1998-07-01), None
patent: 98/37203 (1998-08-01), None
patent: 99/13094 (1999-03-01), None
patent: 99/33996 (1999-07-01), None
patent: 00/11189 (2000-03-01), None
Cell, vol. 86, pp. 917-927, Sep. 20, 1996, Anion Exchanger 1 (Band 3) Is Required to Prevent Erythrocyte Membrane Surface Loss but Not to Form the Membrane Skeleton by L. L. Peters et al.
Biochemistry, month unavailable, 1999, 38, pp. 15388-15397, Species-Specific Inhibition of Inosine 5′-Monophosphate Dehydrogenase by Mycophenolic Acid by J. A. Digits and L. Hedstrom.
Current Medicinal Chemistry, month unavailable, 1999, 6, pp. 575-597, Mizoribine and Mycophenolate Mofetil by H. Ishikawa.
Current Medicinal Chemistry, month unavailable, 1999, 6, pp. 537-543, Differential Signatures of Bacterial and Mammaliam IMP Dehydrogenase Enzymes by R. Zhang et al.
Current Medicinal Chemistry; month unavailable, 1999, 6, pp. 519-536, IMP Dehydrogenase: Structural Aspects of Inhibitor Binding by B. M. Goldstein and T. D. Colby.
Antimicrobial Agents and Chemotherapy, vol. 41, No. 1, Jan. 1997, pp. 40-48, IMP Dehydrogenase fromPneumoscystis cariniias a Potential Drug Target by M. J. O'Gara et al.
Journal of Bacteriology, Apr. 1997, pp. 2331-2338, vol. 179, No. 7, Overexpression of a Cloned IMP Dehydrogenase Gene ofCandida albicansConfers Resistance to the Specific Inhibitor Mycrophenolic Acid by G. A. Köhler, T. C. White and N. Agabian.
The Journal of Anibiotics, vol. XXII, No. 4, pp. 165-169, Apr. 1969, Some Biological Properties of Mycophenolic Acid by T. Noto, M. Sawada, K. Ando and K. Koyama.
Farazi T et al: “Isolation and characterization of mycophenolic acid-resistant mutants of inosine-5′-monophosphate dehydrogenase.” The Journal of Biological Chemistry. United States Jan. 10, 1997, Bd. 272, Nr. 2, Jan. 10, 1997, Seiten 961-965, XP002234558, ISSN: 0021-9258, das ganze Dokument.
Anderson W K et al: “Synthesis and modeling studies with monocyclic analogues of mycophenolic acid.” Journal of Medicinal Chemistry. United States Jan. 5, 1996, Bd. 39, Nr. 1, Jan. 5, 1996, Seiten 46-55, XP002234559 ISSN: 0022-2623 das ganze Dokument.
Trilateral Project B3b Mutual understanding in search and examination-Report on Comparative study on biotechnology patent practices-Theme Comparative study on reach-through claims. Nov. 5-9, 2001, pp. 1-19 and 41-48.
Gene Bank Acc. No.: NP—013536 (Saccharomyces cerevisiae) submitted by the Department of Genetics, Stanford University, Saccharomyces Genome Database, Stanford, CA 94305-5120, Nov. 99.
Acta Chemica Sandinavic 1 3, (month unavailable) 19949, pp. 1343-1349, Erik rennerfelt, The Effect of Some Antibiotic Substances on the Germination of the Conidia of Polyporus annosus Fr.
Gen Bank Acc. No.: NP—009435 (Saccharomyces cerevisiae), submitted by National Center for Biotechnology, Information, NIH, Bethesda, MD 20894, USA, Nov. 99.
Gen Bank Acc. No.: NP—013656 (Saccharomyces cerevisiae), submitted by Department of Genetics, Stanford University, Saccharomyces Genome Database, Stanford, CA 94305-5120, Nov. 99.
Gen Bank Acc. No.: NP—012088 (Saccharomyces cerevisiae), submitted by the Department of Genetics, Stanford University, Saccaromyces Genome Database, Stanford, CA 29305-5120, Nov. 99.
Gen Bank Acc. No.: XP—711825 (Candida albicans) submitted by Kohler et al, Uni Würzburg 1997.
Gen Bank Acc. No.: AF196975 (Pneumocystis carinii), submitted by Pharmacology, Indiana University School of Medicine, 635 Barnhill Dr., Indianapolis, IN 46202, USA, Oct. 1999.
Sequenzvergleich auf Aminosäureebene der Sequenz von Ustilago maydis (Streitpatent, SEQ ID No.:2 mit D3, D9, D10, D11, D12 und D13.
Infection and Immunity, Nov. 1999, vol. 67, No. 11, pp. 3157-6160, Charles F. Thomas, Jr. et al, “Analysis of Pneumocystiscariniiintrons”.
Biochemical Society Transactions, (month unavailable) 1986, p. 260, Joseph A. Gallagher et al, “The action of mycophenotic acid onCandida albicans”.
Congrés International De Botanique, (month unavailable) 1954, pp. 111-113, P. W. Brian, “Some Antifungal natibiotics”.
Aichinger Christian
Kuck Karl-Heinz
Li Volkhart
Schreier Peter
Voerste Arnd
Bayer Cropscience AG
Graser Jennifer E.
Harmuth Raymond J.
LandOfFree
Polypeptides for identifying fungicidally active compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polypeptides for identifying fungicidally active compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptides for identifying fungicidally active compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3798790